DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Jiang Z, Yan M, Hu X. et al.
Pyrotinib combined with capecitabine in women with HER2+ metastatic breast cancer previously treated with trastuzumab and taxanes: A randomized phase III study.
J Clin Oncol 2019;
DOI: 10.1200/JCO.2019.37.15_suppl.1001.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.